Facebook
Linkedin
Twitter
Home
Phil’s Posts
MEMBERS ONLY
Top Trades
Virtual Portfolio Review
Webinars
BNN Money Talk
Market Charts
AI
Biotech
Perspectives
Politics
Science
Strategy
Tech
Trading Education
Contact Us
An invitation from Phil
SIGN IN
SUBSCRIBE
Search
Sign in
Welcome! Log into your account
your username
your password
Log in With Facebook
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
-9.2
C
New York
Monday, December 23, 2024
Sign In
Home
Phil’s Posts
MEMBERS ONLY
Top Trades
Virtual Portfolio Review
Webinars
BNN Money Talk
Market Charts
AI
Biotech
Perspectives
Politics
Science
Strategy
Tech
Trading Education
Contact Us
An invitation from Phil
SIGN IN
SUBSCRIBE
Home
Biotech
Biotech
AI
Biotech
BNN Money Talk
Charts
Climate
Covid
Biotech
The First Sleep Apnea Drug Is Here
Ilene
-
December 21, 2024
Biotech
Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps
Ilene
-
December 20, 2024
Biotech
Carfentanil is 100 times more potent than fentanyl, and it’s killing people
Ilene
-
December 19, 2024
Biotech
Endo’s End Around: How One of the Nation’s Largest Opioid Makers Escaped a $7 Billion Federal Penalty
Ilene
-
December 17, 2024
Biotech
The Medicines Company: Insider Buying
Ilene
-
December 9, 2016
Biotech
Epizyme – A Waiting Game
Ilene
-
August 22, 2016
Biotech
This Is Why Biotech Stocks May Explode Again
Ilene
-
May 7, 2016
Biotech
Endo International plc – Ordinary Shares (ENDP) Collapses Taking Hedge Fund Returns With It
Ilene
-
May 6, 2016
Biotech
Cantor Says Relypsa’s Veltassa Metrics Look Favorable
Ilene
-
May 5, 2016
Biotech
PRGO, VRX and the Papa of “Strong Shareholder Orientation”
Ilene
-
April 28, 2016
Biotech
Sarepta Plunges 50% After FDA Rejects Key Drug
Ilene
-
April 26, 2016
Biotech
Perrigo Company plc (PRGO) Tanks As CEO Leaves For Valeant (VRX)
Ilene
-
April 25, 2016
1
...
103
104
105
...
112
Page 104 of 112
Stay Connected
156,328
Fans
Like
396,312
Followers
Follow
2,330
Subscribers
Subscribe
Latest
Markets
Trump and the Fake Debt Limit
Markets
Nail The Interview: Answer ‘Why Should We Hire You’ Like A Pro
Markets
Things Are Terrible in Europe, and They’re Only Going to Get Worse
Markets
China Wants This Deal to Fail. Don’t Let That Happen.
Markets
How AI Is Quietly Transforming E-Commerce Search And Discovery
Load more